SAN DIEGO, CA -- (MARKET WIRE) -- November 16, 2006 -- Aegis Therapeutics, a leader in intranasal drug delivery, will present a talk entitled: “High-Efficiency Transmucosal Delivery of Peptide and Protein Therapeutics” at the “2nd Modern Drug Discovery & Development Summit” presented by GTCbio. Dr. Edward T. Maggio, President and CEO of Aegis, will describe the application of Aegis’ Intravail™ non-invasive drug delivery technology, and Aegis’ ProTek™ protein stabilization technology to specific peptide and protein therapeutics. The presentation is scheduled for Tuesday, December 5, 2006 at the Pennsylvania Convention Center, Philadelphia, PA.
